Acute and Chronic Prostatitis

John C. Lam, MD
William Stokes, MD

American Family Physician. 2024;110(1):45-51.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Prostatitis is a common clinical syndrome classified into four categories: acute bacterial, chronic bacterial, chronic prostatitis/chronic pelvic pain syndrome, and asymptomatic. Bacterial prostatitis (acute and chronic) is primarily diagnosed with history and microbiologic studies, although physical examination can be helpful to localize infection within the genitourinary system. Bacterial prostatitis is treated with antibiotics; the span of treatment is guided by the duration of symptoms and presence of complications. Chronic prostatitis/chronic pelvic pain syndrome is the most common form of prostatitis and is a diagnosis of exclusion with no standardized treatments. Asymptomatic prostatitis does not require treatment and is usually diagnosed incidentally during the workup for other urologic presentations.

JOHN C. LAM, MD, FRCPC, is a clinical instructor in the Division of Infectious Diseases, Department of Medicine, University of California Los Angeles.

WILLIAM STOKES, MD, FRCPC, is a clinical lecturer at the Provincial Laboratory for Public Health, Alberta Precision Laboratories, Canada; the Department of Pathology and Laboratory Medicine at the University of Alberta, Edmonton, Canada; and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada.

Address correspondence to John C. Lam, MD, FRCPC, at johlam@alumni.ucalgary.ca.

Author disclosure: No relevant financial relationships.

  1. 1.Nickel JC, Downey J, Hunter D, et al. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001;165(3):842-845.
  2. 2.Mehik A, Hellström P, Lukkarinen O, et al. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int. 2000;86(4):443-448.
  3. 3.Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia. 2003;35(5):252-257.
  4. 4.Lam JC, Lang R, Stokes W. How I manage bacterial prostatitis. Clin Microbiol Infect. 2023;29(1):32-37.
  5. 5.Sharp VJ, Takacs EB, Powell CR. Prostatitis: diagnosis and treatment. Am Fam Physician. 2010;82(4):397-406.
  6. 6.Yoon BI, Kim S, Han DS, et al. Acute bacterial prostatitis: how to prevent and manage chronic infection?. J Infect Chemother. 2012;18(4):444-450.
  7. 7.Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis. 2010;50(12):1641-1652.
  8. 8.Acosta H, Sadahira T, Sekito T, et al. Post-prostate biopsy acute bacterial prostatitis and screening cultures using selective media: an overview. Int J Urol. 2022;29(6):486-493.
  9. 9.Wise GJ, Schlegel PN. Sterile pyuria. N Engl J Med. 2015;372(11):1048-1054.
  10. 10.Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006;7(4):320-328.
  11. 11.Nickel JC, Elhilali M, Vallancien G; ALF-ONE Study Group. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. BJU Int. 2005;95(4):571-574.
  12. 12.Etienne M, Pestel-Caron M, Chapuzet C, et al. Should blood cultures be performed for patients with acute prostatitis?. J Clin Microbiol. 2010;48(5):1935-1938.
  13. 13.Coker TJ, Dierfeldt DM. Acute bacterial prostatitis: diagnosis and management. Am Fam Physician. 2016;93(2):114-120.
  14. 14.Nickel JC. Prostatitis. Can Urol Assoc J. 2011;5(5):306-315.
  15. 15.Charalabopoulos K, Karachalios G, Baltogiannis D, et al. Penetration of antimicrobial agents into the prostate. Chemotherapy. 2003;49(6):269-279.
  16. 16.Ulleryd P, Sandberg T. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up. Scand J Infect Dis. 2003;35(1):34-39.
  17. 17.Ha US, Kim ME, Kim CS, et al. Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease. Int J Antimicrob Agents. 2008;31(suppl 1):S96-S101.
  18. 18.Lee DS, Choe HS, Kim HY, et al. Acute bacterial prostatitis and abscess formation. BMC Urol. 2016;16(1):38.
  19. 19.Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents. 1999;11(3–4):205-211 , discussion 213–216.
  20. 20.Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med. 2006;355(16):1690-1698.
  21. 21.Nickel JC, Shoskes D, Wang Y, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?. J Urol. 2006;176(1):119-124.
  22. 22.Perletti G, Marras E, Wagenlehner FME, et al. Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database Syst Rev. 2013(8):CD009071.
  23. 23.Xiong S, Liu X, Deng W, et al. Pharmacological interventions for bacterial prostatitis. Front Pharmacol. 2020;11:504.
  24. 24.Polackwich AS, Shoskes DA. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 2016;19(2):132-138.
  25. 25.Zhang J, Liang C, Shang X, et al. Chronic prostatitis/chronic pelvic pain syndrome: a disease or symptom? Current perspectives on diagnosis, treatment, and prognosis. Am J Mens Health. 2020;14(1) ): 1557988320903200.
  26. 26.Maeda K, Shigemura K, Fujisawa M. A review of current treatments for chronic prostatitis/chronic pelvic pain syndrome under the UPOINTS system. Int J Urol. 2023;30(5):431-436.
  27. 27.Khattak AS, Raison N, Hawazie A, et al. Contemporary management of chronic prostatitis. Cureus. 2021;13(12):e20243.
  28. 28.Nickel JC, Downey J, Clark J, et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62(4):614-617.
  29. 29.Anderson RU, Wise D, Sawyer T, et al. 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol. 2011;185(4):1294-1299.
  30. 30.Nickel JC. Treatment of chronic prostatitis/chronic pelvic pain syndrome. Int J Antimicrob Agents. 2008;31(suppl 1):S112-S116.
  31. 31.Küçük EV, Suçeken FY, Bindayi A, et al. Effectiveness of acupuncture on chronic prostatitis-chronic pelvic pain syndrome category IIIB patients: a prospective, randomized, nonblinded, clinical trial. Urology. 2015;85(3):636-640.
  32. 32.Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236-237.
  33. 33.Holt JD, Garrett WA, McCurry TK, et al. Common questions about chronic prostatitis. Am Fam Physician. 2016;93(4):290-296.
  34. 34.Stevermer JJ, Easley SK. Treatment of prostatitis. Am Fam Physician. 2000;61(10):3015-3022.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.